The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
References (24)
- et al.
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: ThePCI-CURE study
Lancet
(2001) Accounting for future costs in medical costeffectiveness analysis
J Health Econ
(1997)Two Essays in Health Economics: Consumption and Production by Age, with Emphasis on Health Care Expenditures and Economic Evaluation ofBeta-Blocker Therapy in Heart Failure
(2001)- et al.
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
N Engl J Med
(1997) - et al.
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation
N Engl J Med
(2001) - et al.
Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: A longterm model based on the CURE trial
J Intern Med
(2004) - et al.
The costeffectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study
Eur J Cardiovasc Prev Rehabil
(2004) - et al.
Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary intervention in the CURE trial: The PCI-CURE economic analysis
- et al.
Primer on medical decision analysis: Part 5-Working with Markov processes
Med Decis Making
(1997) Markov modeling, analysis and microstimulation with the health care module
Markov models in medical decision making: A practical guide
Med Decis Making
(1993)
Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients
Med Decis Making
(2000)
Cited by (0)
Copyright © 2005 Excerpta Medica, Inc. Published by Elsevier Inc. All rights reserved.